Advanced Search

Technical Analysis for ANVS - Annovis Bio, Inc.

Grade Last Price % Change Price Change
F 35.4 -2.91% -1.06
ANVS closed up 5.71 percent on Monday, September 27, 2021, on 23 percent of normal volume.
8 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical ANVS trend table...
Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup -2.91%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.91%
Crossed Above 20 DMA Bullish -2.91%
Fell Below 20 DMA Bearish 2.64%
1,2,3 Retracement Bearish Bearish Swing Setup 2.64%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.64%
Doji - Bearish? Reversal 2.64%
1,2,3 Retracement Bearish Bearish Swing Setup -0.08%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.08%
Crossed Above 20 DMA Bullish -0.08%
Older End-of-Day Signals for ANVS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 3 hours ago
Possible Inside Day about 3 hours ago
60 Minute Opening Range Breakout about 4 hours ago
Down 3% about 7 hours ago
Down 2 % about 7 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Psychiatric Diagnosis Mild Neurodegeneration Amyloid Nervous System Alzheimer's Neurodegenerative Disorders Cognitive Disorders Learning Disabilities Cognitive Impairment Neuroprotection Gladstone Institutes Parkinson's Diseases

Is ANVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Sep 28 CLASS ACTION UPDATE for ARDX, ANVS and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Sep 28 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YALA, PHG and ANVS
Sep 27 INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits Filed on Behalf of ANVS, HNST, SAM Investors, Lead Plaintiff Deadlines Set
Sep 27 The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ARDX, ANVS and VIEW
Sep 27 CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Has Been Filed Against Annovis Bio, Inc.
Sep 26 Rosen, Global Investor Counsel, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important October 18 Deadline in Securities Class Action - ANVS
Sep 26 The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATVI, YALA and ANVS
Sep 25 Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against Annovis Bio, Inc.
Sep 25 (ANVS) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel Regarding Leading Annovis Bio Class Action Lawsuit
Sep 25 ANVS, PYPL, SAVA, SESN INVESTOR ALERT: CLAIMSFILER REMINDS SHAREHOLDERS of Lead Plaintiff Deadline in Class Action Lawsuits
See more ANVS news...

Indicators

Indicator Value
52 Week High 131.9999
52 Week Low 4.14
Average Volume 630,086
200-Day Moving Average 39.47
50-Day Moving Average 48.34
20-Day Moving Average 34.52
10-Day Moving Average 33.14
Average True Range 3.53
ADX 32.96
+DI 15.89
-DI 22.28
Chandelier Exit (Long, 3 ATRs) 29.11
Chandelier Exit (Short, 3 ATRs) 39.90
Upper Bollinger Bands 38.53
Lower Bollinger Band 30.51
Percent B (%b) 0.74
BandWidth 23.21
MACD Line -3.21
MACD Signal Line -4.60
MACD Histogram 1.3889
Fundamentals Value
Market Cap 251.27 Million
Num Shares 6.89 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -224.23
Price-to-Sales 0.00
Price-to-Book 4.43
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.07
Resistance 3 (R3) 40.63 38.66 40.30
Resistance 2 (R2) 38.66 37.49 38.88 40.04
Resistance 1 (R1) 37.56 36.76 38.11 38.00 39.79
Pivot Point 35.59 35.59 35.87 35.81 35.59
Support 1 (S1) 34.49 34.42 35.04 34.93 33.13
Support 2 (S2) 32.52 33.69 32.74 32.88
Support 3 (S3) 31.42 32.52 32.62
Support 4 (S4) 31.86